MANTA Vascular Closure

Device, Hemostasis, Vascular

FDA Premarket Approval P180025 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Adjustment to the collagen plug weight acceptance criterion for the 18f manta vcd.

DeviceMANTA Vascular Closure
Classification NameDevice, Hemostasis, Vascular
Generic NameDevice, Hemostasis, Vascular
ApplicantEssential Medical, Inc.
Date Received2019-04-18
Decision Date2019-05-15
PMAP180025
SupplementS002
Product CodeMGB
Advisory CommitteeCardiovascular
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address Essential Medical, Inc. 260 Sierra Drive suite 120 exton, PA 19341

Supplemental Filings

Supplement NumberDateSupplement Type
P180025Original Filing
S009 2021-02-10 Normal 180 Day Track
S008 2020-08-21 30-day Notice
S007 2020-05-04 30-day Notice
S006 2020-01-06 Real-time Process
S005 2019-07-23 30-day Notice
S004
S003
S002 2019-04-18 30-day Notice
S001

NIH GUDID Devices

Device IDPMASupp
00856279007079 P180025 000
00856279007062 P180025 000
20841156109957 P180025 000
20841156109933 P180025 000
20841156109926 P180025 000
20841156109902 P180025 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.